Tenon Medical, Inc. financial data

Symbol
TNON, TNONW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
104 Cooper Ct., Los Gatos, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 210 % +13.7%
Quick Ratio 20.1 % +62.9%
Debt-to-equity 149 % -23.9%
Return On Equity -409 % +39%
Return On Assets -164 % +27.6%
Operating Margin -414 % +51.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.14M shares +26.9%
Common Stock, Shares, Outstanding 3.14M shares +26.9%
Entity Public Float 4.89M USD -72.1%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 877 shares +208%
Weighted Average Number of Shares Outstanding, Diluted 877 shares +208%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.32M USD +38.3%
Cost of Revenue 1.4M USD -27.3%
Research and Development Expense 2.73M USD -17%
Selling and Marketing Expense 5.38M USD -48.3%
General and Administrative Expense 7.54M USD +3.33%
Operating Income (Loss) -13.7M USD +33.1%
Nonoperating Income (Expense) 14K USD -91.4%
Net Income (Loss) Attributable to Parent -13.7M USD +32.6%
Earnings Per Share, Basic 4.78 USD/shares +68.9%
Earnings Per Share, Diluted 4.78 USD/shares +68.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.16M USD +172%
Accounts Receivable, after Allowance for Credit Loss, Current 876K USD +13.3%
Inventory, Net 607K USD +28.1%
Assets, Current 11.2M USD +125%
Property, Plant and Equipment, Net 906K USD -5.23%
Operating Lease, Right-of-Use Asset 463K USD -34.2%
Assets 13M USD +78.2%
Accounts Payable, Current 1.09M USD +43.3%
Employee-related Liabilities, Current 482K USD
Accrued Liabilities, Current 908K USD +59%
Liabilities, Current 3.18M USD +3.02%
Operating Lease, Liability, Noncurrent 216K USD -56.3%
Liabilities 4.85M USD +0.98%
Accumulated Other Comprehensive Income (Loss), Net of Tax -46K USD +54%
Retained Earnings (Accumulated Deficit) -65.7M USD -26.4%
Stockholders' Equity Attributable to Parent 8.19M USD +225%
Liabilities and Equity 13M USD +78.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.34M USD +34.6%
Net Cash Provided by (Used in) Financing Activities 4.37M USD
Net Cash Provided by (Used in) Investing Activities -119K USD -103%
Common Stock, Shares Authorized 130M shares 0%
Common Stock, Shares, Issued 3.14M shares +26.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.96M USD +86.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.16M USD +172%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 12.4M USD +45.2%
Deferred Tax Assets, Gross 12.6M USD +42.5%
Operating Lease, Liability 495K USD -33.4%
Depreciation 105K USD +128%
Payments to Acquire Property, Plant, and Equipment 84K USD -34.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.6M USD +32.9%
Lessee, Operating Lease, Liability, to be Paid 531K USD -36%
Property, Plant and Equipment, Gross 1.46M USD +27.6%
Operating Lease, Liability, Current 279K USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 144K USD -52.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 310K USD +313%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 36K USD -58.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 144K USD -53.5%
Deferred Tax Assets, Operating Loss Carryforwards 9.5M USD +35.8%
Unrecognized Tax Benefits 79K USD +108%
Lessee, Operating Lease, Liability, to be Paid, Year Four 144K USD 0%
Operating Lease, Payments 74K USD +2.78%
Additional Paid in Capital 70.1M USD +28.5%
Depreciation, Depletion and Amortization 100K USD +300%
Deferred Tax Assets, Net of Valuation Allowance 178K USD -38%
Share-based Payment Arrangement, Expense 4.12M USD +88.8%
Interest Expense 34K USD